Semantic Scholar uses AI to extract papers important to this topic.
BACKGROUND & AIMS
Ramosetron, a serotonin (5-hydroxytryptamine)-3 receptor antagonist with high selectivity, reduced stress… Expand Chemotherapy-induced nausea and vomiting (CINV) is associated with a significant deterioration in quality of life. The… Expand Chemotherapeutic agents, including 5‐fluorouracil (5‐FU), frequently cause intestinal mucositis resulting in severe diarrhoea and… Expand Background The purpose of this study was to evaluate the effect of an aprepitant, neurokinin-1(NK1) receptor antagonist, for… Expand BACKGROUND
Ramosetron is a new selective 5-hydroxytryptamine type 3 (5-HT(3)) receptor antagonist that reportedly has more potent… Expand BackgroundPatients undergoing general anesthesia for laparoscopic cholecystectomy are at high risk for postoperative nausea and… Expand Study Design. A prospective, randomized, double-blind clinical trial. Objective. To compare the effect of ramosetron with that of… Expand Ramosetron is a selective serotonin 5-HT3 receptor antagonist with an affinity higher than that of the previously available drugs… Expand UNLABELLED
In a prospective, randomized, double-blinded, placebo-controlled trial, we evaluated the efficacy of ramosetron at… Expand UNLABELLED
In a prospective, randomized, double-blinded study, we evaluated the efficacy of granisetron and ramosetron for… Expand